ArticleMolecular biology reports2025
Circular RNAs MTO1 and ZNF292 as potential diagnostic biomarkers in HIV patients treated with antiretroviral therapy.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionCircular RNAs (circRNAs) are unique, abundant, and stable non-coding RNAs having regulatory roles and potential clinical significance. This study investigates the expression profiles and diagnostic efficacy of specific circRNAs in HIV-infected patients. METHODOLOGY: Blood samples from 195 HIV-infected patients (156 were viremic, 39 were non-viremic (antiretroviral therapy (ART)-suppressed) and 40 healthy controls were collected. The expression of six circRNAs in whole blood from HIV-infected patients and healthy controls was analyzed using quantitative real-time PCR. The diagnostic potential of circRNAs was assessed using receiver operating characteristic (ROC) curve analysis. Bioinformatics approaches were then used to identify competing endogenous RNA (ceRNA) networks of circRNAs with microRNAs (miRNAs) and messenger RNAs (mRNAs), their biological functions, and related pathways.
resultsThis study demonstrated that circRNAs were differentially expressed in HIV infection, highlighting that circMTO1 (viremic FC: 3.87, non-viremic FC: 3.61) and circZNF292 (viremic FC: 3.24, non-viremic FC: 3.0) may act as robust biomarkers for distinguishing HIV patients from healthy controls. The ROC curve analysis showed that for circMTO1 expression, the area under curve (AUC) value was 0.7492 (p = 0.0077), and for circZNF292 expression AUC value was 0.7231 (p = 0.0176). This study has also revealed the involvement of circMTO1 and circZNF292 in key regulatory pathways associated with immune regulation and HIV progression.
conclusionIn conclusion, our findings emphasize the importance of circRNAs in understanding HIV pathogenesis and propose their clinical significance in diagnostic and therapeutic strategies.
Indexed as
Identifiers
40694227What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.